Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)
Abstract Background: Australia has had a framework for legal medicinal cannabis since 2016, yet prior online surveys in 2016 and…
Abstract Background: Australia has had a framework for legal medicinal cannabis since 2016, yet prior online surveys in 2016 and…
Abstract Background: Cannabidiol (CBD), a major cannabinoid of Cannabis sativa, is widely consumed in prescription and non-prescription products. While CBD…
Abstract Introduction: Many countries are changing their regulations for prescribing medical cannabis. As gatekeepers, physicians significantly impact patient access to…
Abstract A regulatory framework allowing legal access to medicinal cannabis (MC) products has operated in Australia since November 2016. MC…
Abstract Inflammation often develops from acute, chronic, or auto-inflammatory disorders that can lead to compromised organ function. Cannabis (Cannabis sativa)…
Abstract Background: Little is known about cannabis use for insomnia in individuals with depression, anxiety, and comorbid depression and anxiety.…
Abstract Concomitant use of cannabis with other drugs may lead to cannabis–drug interactions, mainly due to the pharmacokinetic mechanism involving…
Abstract Background: In 2018, an innovative, State government‐funded cannabis medicines drug information service was established for health professionals in New…
Abstract Introduction: The cannabinoid Δ9-tetrahydrocannabinolic acid (Δ9-THCA) has long been suggested in review articles and anecdotal reports to be anticonvulsant;…
Abstract Objective: This study sought to investigate the perceptions, barriers, and drivers associated with medicinal cannabis use among Australian women…